Voxel SA
WSE:VOX
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
67
123
|
| Price Target |
|
We'll email you a reminder when the closing price reaches PLN.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Voxel SA
Cost of Revenue
Voxel SA
Cost of Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
V
|
Voxel SA
WSE:VOX
|
Cost of Revenue
-zł443m
|
CAGR 3-Years
-3%
|
CAGR 5-Years
-25%
|
CAGR 10-Years
-19%
|
|
Voxel SA
Glance View
Voxel SA engages in the provision of medical services. The company is headquartered in Krakow, Woj. Malopolskie and currently employs 546 full-time employees. The company went IPO on 2011-10-11. The company provides services in the fields of diagnostic imaging, teleradiology and outsourcing, as well as information technology (IT) systems for hospitals and diagnostic centers. As of December 31, 2011, the Company operated two subsidiaries, 95.24%-owned Alteris SA and wholly owned CDO Sp. z o.o. On November 7, 2012, the Company sold its entire stake in Centrum Diagnostyki i Terapii Onkologicznej Sp. z o.o.
See Also
What is Voxel SA's Cost of Revenue?
Cost of Revenue
-443m
PLN
Based on the financial report for Jun 30, 2024, Voxel SA's Cost of Revenue amounts to -443m PLN.
What is Voxel SA's Cost of Revenue growth rate?
Cost of Revenue CAGR 10Y
-19%
Over the last year, the Cost of Revenue growth was -40%. The average annual Cost of Revenue growth rates for Voxel SA have been -3% over the past three years , -25% over the past five years , and -19% over the past ten years .
You don't have any saved screeners yet
